StratumSkin science, cited
Ingredient Index

Ageing · Scarring

Exosomes

Cell-derived vesicles

Overall grade DTypical strength Any2 sources

The current most-expensive thing in the clinic. The laboratory science is legitimately interesting. The human evidence is a handful of tiny unblinded studies, and topical products are not regulated as the medicines they are described as. Wait for this one.

Claim by claim

DSkin rejuvenationPreliminary human data only. Trials are ongoing, not concluded.
DRegulationSold as cosmetics while described as medicine.

References

  1. Glass GE. Cosmeceuticals: the principles and practice of skin rejuvenation by nonprescription topical therapy. Aesthetic Surgery Journal Open Forum, 2020.CReview of cosmeceutical categories and their evidence·States plainly that high-quality clinical trial data are lacking for matrikine peptides, and that most cosmeceutical studies are run by the manufacturer of the product being tested.PubMed 36776759Read the source
  2. Chan L, et al. Cosmeceuticals in photoaging: a review. Skin Research and Technology, 2024.CSystematic review of botanicals, peptides and depigmenting agents·Covers green tea, centella, licorice, resveratrol, tea tree oil, argireline and peptides. Rates peptide evidence strongest of the group. Botanical evidence is largely preclinical or Level V.PubMed 39233460

Your turn

Did this hold up? Tell us honestly — especially if it didn’t.

Anonymous. Stored in your browser.

The Sunday study

One paper a week, explained properly

We pick a single new study, tell you what it measured, how many people it measured it in, and whether it should change anything you're doing — plus the two articles we published that week. No panic, and no hype.

We don't recommend products yet. When we do, they'll be things you can actually buy in India, any affiliate link will be labelled as one, and a commission will never buy a recommendation.

One email each Sunday. Unsubscribe in one click.